130 related articles for article (PubMed ID: 34216101)
1. Analysis of rare coding variants in 200,000 exome-sequenced subjects reveals novel genetic risk factors for type 2 diabetes.
Curtis D
Diabetes Metab Res Rev; 2022 Jan; 38(1):e3482. PubMed ID: 34216101
[TBL] [Abstract][Full Text] [Related]
2. Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes.
Deaton AM; Parker MM; Ward LD; Flynn-Carroll AO; BonDurant L; Hinkle G; Akbari P; Lotta LA; ; ; Baras A; Nioi P
Sci Rep; 2021 Nov; 11(1):21565. PubMed ID: 34732801
[TBL] [Abstract][Full Text] [Related]
3. Weighted burden analysis in 200,000 exome-sequenced subjects characterises rare variant effects on BMI.
Curtis D
Int J Obes (Lond); 2022 Apr; 46(4):782-792. PubMed ID: 35067685
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Recessive Effects of Coding Variants on Common Clinical Phenotypes in Exome-Sequenced UK Biobank Participants.
Curtis D
Hum Hered; 2024; 89(1):1-7. PubMed ID: 38342085
[TBL] [Abstract][Full Text] [Related]
5. Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia.
Curtis D
Mol Genet Metab; 2020; 131(1-2):277-283. PubMed ID: 32747172
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing and genetic testing for MODY.
Johansson S; Irgens H; Chudasama KK; Molnes J; Aerts J; Roque FS; Jonassen I; Levy S; Lima K; Knappskog PM; Bell GI; Molven A; Njølstad PR
PLoS One; 2012; 7(5):e38050. PubMed ID: 22662265
[TBL] [Abstract][Full Text] [Related]
7. GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health.
Zhao Y; Stankovic S; Koprulu M; Wheeler E; Day FR; Lango Allen H; Kerrison ND; Pietzner M; Loh PR; Wareham NJ; Langenberg C; Ong KK; Perry JRB
Nat Commun; 2021 Jul; 12(1):4178. PubMed ID: 34234147
[TBL] [Abstract][Full Text] [Related]
8. Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk.
Curtis D
J Hum Genet; 2024 Jun; 69(6):255-262. PubMed ID: 38454133
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.
Flannick J; Mercader JM; Fuchsberger C; Udler MS; Mahajan A; Wessel J; Teslovich TM; Caulkins L; Koesterer R; Barajas-Olmos F; Blackwell TW; Boerwinkle E; Brody JA; Centeno-Cruz F; Chen L; Chen S; Contreras-Cubas C; Córdova E; Correa A; Cortes M; DeFronzo RA; Dolan L; Drews KL; Elliott A; Floyd JS; Gabriel S; Garay-Sevilla ME; García-Ortiz H; Gross M; Han S; Heard-Costa NL; Jackson AU; Jørgensen ME; Kang HM; Kelsey M; Kim BJ; Koistinen HA; Kuusisto J; Leader JB; Linneberg A; Liu CT; Liu J; Lyssenko V; Manning AK; Marcketta A; Malacara-Hernandez JM; Martínez-Hernández A; Matsuo K; Mayer-Davis E; Mendoza-Caamal E; Mohlke KL; Morrison AC; Ndungu A; Ng MCY; O'Dushlaine C; Payne AJ; Pihoker C; ; Post WS; Preuss M; Psaty BM; Vasan RS; Rayner NW; Reiner AP; Revilla-Monsalve C; Robertson NR; Santoro N; Schurmann C; So WY; Soberón X; Stringham HM; Strom TM; Tam CHT; Thameem F; Tomlinson B; Torres JM; Tracy RP; van Dam RM; Vujkovic M; Wang S; Welch RP; Witte DR; Wong TY; Atzmon G; Barzilai N; Blangero J; Bonnycastle LL; Bowden DW; Chambers JC; Chan E; Cheng CY; Cho YS; Collins FS; de Vries PS; Duggirala R; Glaser B; Gonzalez C; Gonzalez ME; Groop L; Kooner JS; Kwak SH; Laakso M; Lehman DM; Nilsson P; Spector TD; Tai ES; Tuomi T; Tuomilehto J; Wilson JG; Aguilar-Salinas CA; Bottinger E; Burke B; Carey DJ; Chan JCN; Dupuis J; Frossard P; Heckbert SR; Hwang MY; Kim YJ; Kirchner HL; Lee JY; Lee J; Loos RJF; Ma RCW; Morris AD; O'Donnell CJ; Palmer CNA; Pankow J; Park KS; Rasheed A; Saleheen D; Sim X; Small KS; Teo YY; Haiman C; Hanis CL; Henderson BE; Orozco L; Tusié-Luna T; Dewey FE; Baras A; Gieger C; Meitinger T; Strauch K; Lange L; Grarup N; Hansen T; Pedersen O; Zeitler P; Dabelea D; Abecasis G; Bell GI; Cox NJ; Seielstad M; Sladek R; Meigs JB; Rich SS; Rotter JI; ; ; ; ; ; ; ; ; ; Altshuler D; Burtt NP; Scott LJ; Morris AP; Florez JC; McCarthy MI; Boehnke M
Nature; 2019 Jun; 570(7759):71-76. PubMed ID: 31118516
[TBL] [Abstract][Full Text] [Related]
10. Nonsynonymous Variants in
Kwak SH; Chae J; Lee S; Choi S; Koo BK; Yoon JW; Park JH; Cho B; Moon MK; Lim S; Cho YM; Moon S; Kim YJ; Han S; Hwang MY; Cho YS; Lee MS; Jang HC; Kang HM; Park T; Cho NH; Kim K; Kim JI; Park KS
Diabetes; 2018 Sep; 67(9):1892-1902. PubMed ID: 29941447
[TBL] [Abstract][Full Text] [Related]
11. Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes.
Majithia AR; Flannick J; Shahinian P; Guo M; Bray MA; Fontanillas P; Gabriel SB; ; ; ; ; Rosen ED; Altshuler D
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13127-32. PubMed ID: 25157153
[TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing reveals novel candidate gene variants for MODY.
Yalçın Çapan Ö; Aydın N; Yılmaz T; Berber E
Clin Chim Acta; 2020 Nov; 510():97-104. PubMed ID: 32645390
[TBL] [Abstract][Full Text] [Related]
13. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.
Cauchi S; Nead KT; Choquet H; Horber F; Potoczna N; Balkau B; Marre M; Charpentier G; Froguel P; Meyre D
BMC Med Genet; 2008 May; 9():45. PubMed ID: 18498634
[TBL] [Abstract][Full Text] [Related]
14. Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank.
Jurgens SJ; Choi SH; Morrill VN; Chaffin M; Pirruccello JP; Halford JL; Weng LC; Nauffal V; Roselli C; Hall AW; Oetjens MT; Lagerman B; vanMaanen DP; ; Aragam KG; Lunetta KL; Haggerty CM; Lubitz SA; Ellinor PT
Nat Genet; 2022 Mar; 54(3):240-250. PubMed ID: 35177841
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
16. Damaging missense variants in
Gardner EJ; Kentistou KA; Stankovic S; Lockhart S; Wheeler E; Day FR; Kerrison ND; Wareham NJ; Langenberg C; O'Rahilly S; Ong KK; Perry JRB
Cell Genom; 2022 Dec; 2(12):None. PubMed ID: 36530175
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing identifies variation in CYB5A and RNF10 associated with adiposity and type 2 diabetes.
Huang K; Nair AK; Muller YL; Piaggi P; Bian L; Del Rosario M; Knowler WC; Kobes S; Hanson RL; Bogardus C; Baier LJ
Obesity (Silver Spring); 2014 Apr; 22(4):984-8. PubMed ID: 24151200
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus.
Gjesing AP; Rui G; Lauenborg J; Have CT; Hollensted M; Andersson E; Grarup N; Sun J; Quan S; Brandslund I; Damm P; Pedersen O; Wang J; Hansen T
J Endocr Soc; 2017 Jun; 1(6):681-690. PubMed ID: 29264522
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel rare variants for anxiety: an exome-wide association study in the UK Biobank.
Pan C; Cheng S; Liu L; Chen Y; Meng P; Yang X; Li C; Zhang J; Zhang Z; Zhang H; Cheng B; Wen Y; Jia Y; Zhang F
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110928. PubMed ID: 38154517
[TBL] [Abstract][Full Text] [Related]
20. The first exome wide association study in Tunisia: identification of candidate loci and pathways with biological relevance for type 2 diabetes.
Dallali H; Boukhalfa W; Kheriji N; Fassatoui M; Jmel H; Hechmi M; Gouiza I; Gharbi M; Kammoun W; Mrad M; Taoueb M; Krir A; Trabelsi H; Bahlous A; Jamoussi H; Messaoud O; Abid A; Kefi R
Front Endocrinol (Lausanne); 2023; 14():1293124. PubMed ID: 38192426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
